James Investment Research Inc Novo Nordisk A S Transaction History
James Investment Research Inc
- $819 Million
- Q4 2024
A detailed history of James Investment Research Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, James Investment Research Inc holds 5,093 shares of NVO stock, worth $427,964. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,093
Previous 8,850
42.45%
Holding current value
$427,964
Previous $1.05 Million
58.4%
% of portfolio
0.05%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,879Shares Held
317MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.68 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.21 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.2 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.12 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.03 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $190B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...